SANOFI
|
(Exact name of registrant as specified in its charter)
|
54 Rue La Boetie
Paris, France, 75008
+33 153774000
|
(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)
|
Contingent Value Right
|
(Title of each class of securities covered by this Form)
|
American Depositary Shares, each representing one half of one ordinary share, par value €2 per share
Ordinary Shares, par value €2 per share
|
(Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)
|
Rule 12g-4(a)(1)
|
☒
|
Rule 12g-4(a)(2)
|
☐
|
Rule 12h-3(b)(1)(i)
|
☒
|
Rule 12h-3(b)(1)(ii)
|
☐
|
Rule 15d-6
|
☐
|
Rule 15d-22(b)
|
☐
|
Date:
|
March 18, 2020
|
By: |
/s/ Alexandra Roger
| |
Name: Alexandra Roger
| ||||
Title: Head of Securities Law and Capital Markets
|
Attachments
- Original document
- Permalink
Disclaimer
Sanofi SA published this content on 18 March 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 March 2020 13:17:12 UTC